CLINICAL_TRIALS
research
· 2017-10-04
Clinical Trial Update: Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD) [Phase 4]
Summary
A Phase 4 trial evaluating home monitoring to reduce treatment burden in neovascular age-related macular degeneration has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Retinal Consultants of Arizona | Conditions: Neovascular Age Related Macular Degeneration | Phase 4 | Status: COMPLETED